Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ironwood Pharmaceuticals Inc IRWD

Healthcare Biotechnology
Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company engaged in advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is engaged in the development of LINZESS (linaclotide) for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Linaclotide is also approved for the treatment of... see more

Recent & Breaking News (NDAQ:IRWD)

Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference

Business Wire March 4, 2015

Ironwood Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference

Business Wire February 23, 2015

Ironwood Pharmaceuticals Provides Fourth Quarter 2014 Investor Update

Business Wire February 12, 2015

Ironwood Reports Positive Top-Line Data from Exploratory Phase IIa Trial Of IW-3718 in Refractory Gastroesophageal Reflux Disease

Business Wire February 4, 2015

Ironwood Pharmaceuticals to Host Fourth Quarter 2014 Investor Update Call

Business Wire January 29, 2015

Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

Business Wire January 5, 2015

Ironwood Pharmaceuticals Initiates Phase IIa Clinical Study of IW-9179 in Diabetic Gastroparesis

Business Wire December 9, 2014

Ironwood Earns $15 Million Milestone from Astellas upon Initiation of Enrollment in Linaclotide Phase III IBS-C Clinical Trial in Japan

Business Wire November 20, 2014

Ironwood Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference

Business Wire November 5, 2014

Ironwood Pharmaceuticals Initiates Phase III Trial of 72 mcg Linaclotide in Adult Patients with Chronic Idiopathic Constipation

Business Wire November 4, 2014

Ironwood Pharmaceuticals Provides Third Quarter 2014 Investor Update

Business Wire November 4, 2014

Ironwood Presents IW-9179 Phase IIa Data at American College of Gastroenterology 2014 Annual Scientific Meeting

Business Wire October 20, 2014

Ironwood Pharmaceuticals Announces Initiation of Phase II Trial of Linaclotide in Adult Patients with Opioid-Induced Constipation

Business Wire October 16, 2014

Ironwood Pharmaceuticals to Host Third Quarter 2014 Investor Update Call

Business Wire October 14, 2014

Ironwood and Actavis to Present Linaclotide Data at the American College of Gastroenterology 2014 Annual Scientific Meeting

Business Wire October 9, 2014

Ironwood Pharmaceuticals Inc. (IRWD) Jumps 5.50% on September 5

Equities.com September 5, 2014

Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

Business Wire September 3, 2014

Ironwood Appoints Two New Senior Executives to Support Continued Growth as a Leader in Gastroenterology

Business Wire September 2, 2014

Ironwood Pharmaceuticals Provides Second Quarter 2014 Investor Update

Business Wire August 4, 2014

Ironwood Pharmaceuticals to Host Second Quarter 2014 Investor Update Call

Business Wire July 7, 2014